Table 1: Clinical and demographic characteristics of the patients.

Group A Group B Group C Total
Localization
Abdominal 4 31 11 46
ORL 1 8 2 11
Cervical 2 2 4
Bone 3 3
Other / combination 9 3 10
Results after COP
> 25% response 48 15 63
< 25 % response 2 1 3
Results after CYM/CYVE
CR 37 14 51
Residual mass Viable tumour 7
Necrotic tissue 6
Primary treatment outcome
CR 6 46 15 67
PR 0
Resistant / progressive disease 1 3 1 5
Death due to disease 7 1 8
Death due to toxicity 2 1 3
Relapse
Local 1 4 5
BM 2 2
Local + BM CNS 2 0
BM + CNS 0
CNS 1 1
Survival rate
2- year OS 100% 83.1% 86.7%
2-year EFS 85.7% 81.1% 81.3%